Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Squamous Intraepithelial Lesions 2Prostatic Neoplasms 2Papillomavirus Infections 2Neuroblastoma 2Melanoma 2Lymphoma, Large B-Cell, Diffuse 2Hemangiosarcoma 2HIV Infections 2Ependymoma 2Colonic Neoplasms 2Breast Neoplasms, Male 2Anus Neoplasms 2Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Urinary Bladder Neoplasms 1Thromboembolism 1Thrombocythemia, Essential 1Stomach Neoplasms 1Stage I Mixed Cell Type Kidney Wilms Tumor 1Small Cell Lung Carcinoma 1Sezary Syndrome 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Rectal Neoplasms 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Watchful Waiting 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Hemangiopericytoma × Watchful Waiting × Clear all
NCT05259605 2025-12-17

Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification

European Organisation for Research and Treatment of Cancer - EORTC

Recruiting
1,650 enrolled
CNS

Ependymoma, Glioma, Hemangiopericytoma, Neoplasms, Germ Cell and Embryonal, Pinealoma, Choroid Plexus Neoplasms, Hemangioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡